SWM
CSTL icon

Spire Wealth Management’s Castle Biosciences CSTL Stock Holding History

Spire Wealth Management’s Portfolio CSTL Stock Details CSTL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.19K Hold
50
– – ﹤0.01% 2106
2026
Q1 		$1.23K Hold
50
– – ﹤0.01% 2115
2025
Q4 		$1.95K Hold
50
– – ﹤0.01% 2107
2025
Q3 		$1.14K Hold
50
– – ﹤0.01% 2253
2025
Q2 		$1.02K Hold
50
– – ﹤0.01% 2277
2025
Q1 		$1K Buy
+50
New +$1.24K ﹤0.01% 2387

Other funds holding CSTL

WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
FBT
First Bank & Trust Brookings, South Dakota $680M AUM 25.36% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return
CWP
Curated Wealth Partners El Segundo, California $774M AUM 5.71% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.12B AUM 34.21% 1-Year Est. Return
TWD
True Wealth Design Akron, Ohio $420M AUM 22.7% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return

Spire Wealth Management's CSTL Position: Q2 2026 in Review

Spire Wealth Management held its Castle Biosciences (CSTL) position steady in Q2 2026 at 50 shares worth $1.19K. The position accounts for ﹤0.01% of the portfolio, ranked #2106.

Spire Wealth Management first reported a position in CSTL in Q1 2025 and has held it in 6 quarters since. The position peaked at $1.95K in Q4 2025. 9 funds tracked by Wall St. Rank hold CSTL as of Q2 2026.

  • Spire Wealth Management held 50 shares of Castle Biosciences worth $1.19K as of Q2 2026.
  • Spire Wealth Management left its Castle Biosciences share count unchanged in Q2 2026.
  • Castle Biosciences made up ﹤0.01% of Spire Wealth Management's portfolio in Q2 2026, its #2106 holding.
  • Spire Wealth Management first reported a position in Castle Biosciences in Q1 2025 and has held it in 6 quarters since.
  • Spire Wealth Management's Castle Biosciences position peaked at $1.95K in Q4 2025.
  • 9 funds tracked by Wall St. Rank held Castle Biosciences as of Q2 2026.

Based on Spire Wealth Management's 13F filing for Q2 2026, filed 15 Jul 2026.